Watch for Bexagliflozin, a New Med for Type 2 Diabetes
September 2023
The new diabetes med, bexagliflozin (Brenzavvy), will pop up on home med lists.
Think of it as similar to other SGLT2 inhibitors for type 2 diabetes...dapagliflozin, empagliflozin, etc.
A big difference is that bexagliflozin will cost about $50/month...versus about $600/month for other SGLT2 inhibitors.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote